196 filings
NT 10-Q
PHGE
BiomX Inc
15 May 24
Notice of late quarterly filing
4:05pm
S-3
PHGE
BiomX Inc
Shelf registration
29 Apr 24
4:31pm
8-K
PHGE
BiomX Inc
15 Apr 24
Departure of Directors or Certain Officers
5:19pm
S-8
PHGE
BiomX Inc
4 Apr 24
Registration of securities for employees
7:46am
10-K
2023 FY
PHGE
BiomX Inc
Annual report
4 Apr 24
6:30am
8-K
l7qmyqt9
3 Apr 24
BiomX Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
7:40am
NT 10-K
708b6w37icz
1 Apr 24
Notice of late annual filing
4:02pm
D
pt18fq2
1 Apr 24
$61.55 mm in equity / options / securities to be acquired, sold $61.55 mm, 34 investors
8:27am
8-K/A
wmi9m atxo1
21 Mar 24
Departure of Directors or Certain Officers
4:18pm
8-K
yp9bhr
18 Mar 24
Completion of Acquisition or Disposition of Assets
7:27am
8-K
0l6wvwo imnaac
6 Mar 24
Form of Parent Stockholder Support Agreement
7:45am
EFFECT
twv4y lak
3 Jan 24
Notice of effectiveness
12:15am
CORRESP
bzar4zfy9dv c5
29 Dec 23
Correspondence with SEC
12:00am
SC TO-I/A
2q6t5
12 Dec 23
Issuer tender offer statement (amended)
4:20pm
8-K
r6cjb3rirtsvr8 uom5
7 Dec 23
Entry into a Material Definitive Agreement
5:29pm
8-K
43kzdnepzvhmk s9jyrm
7 Dec 23
Other Events
4:09pm
8-K
4zg3e
29 Nov 23
Revolutionizing the treatment of Cystic Fibrosis through our unique BOLT Phage therapy platform Investor Presentation / November 2023
6:37am
SC TO-I/A
ocq5cowua2sxr64
28 Nov 23
Issuer tender offer statement (amended)
4:01pm